Apolipoprotein
-
Apolipoprotein Related Products (64)
Related Products (64)
-
Zerlasiran
0 ImagesCat. No.: HY-147425CAS No.: 2646703-64-0Synonyms: SLN360Zerlasiran (SLN360) is a siRNA targeting apolipoprotein A (ApoA). Zerlasiran targets hepatic ApoA synthesis via RNA interference to degrade encoding mRNA. Zerlasiran can be used for the research of atherosclerotic cardiovascular disease and elevated ApoA levels.
-
Pelacarsen
0 ImagesCat. No.: HY-151123CAS No.: 1637637-70-7Synonyms: AKCEA-APO(a)-LRx; ISIS 681257; TQJ230Pelacarsen (ISIS 681257) is a GalNAc3-conjugated 2′-MOE-modified antisense oligonucleotide. Pelacarsen reduces apo (a).
-
2′-O-Methyluridine-d3
0 ImagesCat. No.: HY-W011824SPurity: 99.19%2′-O-Methyluridine-d3 is deuterium labeled 2′-O-Methyluridine (HY-W011824).2’-O-Methyluridine is a modified nucleoside that can be found in T. thermophile tRNA. 2’-O-Methyluridine level in serum is decreased in patients with breast cancer.
-
2′-O-Methyluridine (Standard)
0 Images2′-O-Methyluridine (Standard) is the analytical standard of 2′-O-Methyluridine (HY-W001824). This product is intended for research and analytical applications. 2’-O-Methyluridine is a modified nucleoside that can be found in T. thermophile tRNA. 2’-O-Methyluridine level in serum is decreased in patients with breast cancer.
-
3-Iodo-L-thyronine
0 ImagesSynonyms: 3-Monoiodothyronine3-Iodo-L-thyronine (3-Monoiodothyronine) is a thyroid hormone metabolite. 3-iodo-L-thyronine can bind to apolipoprotein B-100 (apoB-100).
-
LVGRQLEEFL (mouse) TFA
0 ImagesCat. No.: HY-P5169ALVGRQLEEFL (mouse) TFA can be named as G * peptide, corresponding to amino acids 113 to 122 in apolipoprotein J ([113,122] apoJ)}. LVGRQLEEFL (mouse) TFA exhibits anti-inflammatory and anti-atherogenic properties. LVGRQLEEFL (mouse) TFA can be added to an apoJ mimetic, to form HM-10/10 peptide, which is a mimetic peptide and a novel chimeric high density lipoprotein. HM-10/10 peptide protects retinal pigment epithelium (RPE) and photoreceptors from oxidant induced cell death.
-
Sultosilic acid piperazine salt
0 ImagesCat. No.: HY-130587CAS No.: 57775-27-6Synonyms: Piperazine sultosylate; A-585Sultosilic acid piperazine salt (Piperazine sultosylate; A-585) is a lipid-lowering agent. Sultosilic acid piperazine salt modifies the blood lipids levels, reduces platelet adhesiveness without promoting peroxisomal activity of hepatocytes or producing other adverse side-effects.
-
Mipomersen sodium scrambled negative control
0 ImagesCat. No.: HY-108764BMipomersen sodium scrambled negative control is the sequence scrambled negative control of Mipomersen sodium.
-
Pelacarsen sodium scrambled negative control
0 ImagesCat. No.: HY-151123CPelacarsen sodium scrambled negative control is the sequence scrambled negative control of Pelacarsen sodium.
-
Zerlasiran sodium scrambled negative control
0 ImagesCat. No.: HY-147425CSynonyms: SLN360 sodium scrambled negative controlZerlasiran (SLN360) sodium scrambled negative control is the sequence scrambled negative control of Zerlasiran sodium (HY-147425A). Zerlasiran sodium is a siRNA targeting apolipoprotein A (ApoA). Zerlasiran sodium targets hepatic ApoA synthesis via RNA interference to degrade encoding mRNA. Zerlasiran sodium can be used for the research of atherosclerotic cardiovascular disease and elevated ApoA levels.
-
Lp(a)-IN-8
0 ImagesCat. No.: HY-173322CAS No.: 3070206-18-4Lp(a)-IN-8 is a Lp(a) assembly inhibitor with an IC50 of 0.749 nM. Lp(a)-IN-8 can be used in studies related to cardiovascular diseases and elevated plasma Lp(a) levels.
-
Alcedaplin
0 ImagesCat. No.: HY-187856CAS No.: 2956780-66-6Synonyms: MZE829Alcedaplin (MZE829) is an Apolipoprotein L1 (ApoL1) function inhibitor.
-
APOL1-IN-3
0 ImagesCat. No.: HY-176196CAS No.: 2762826-72-0APOL1-IN-3 (Compound 1) is an APOL1 inhibitor. APOL1-IN-3 can be used in the research of kidney diseases.
-
APL180
0 ImagesCat. No.: HY-P6365ACAS No.: 388566-97-0Synonyms: L-4FAPL180 (L-4F) is an apolipoprotein A-I mimic peptide, that improves the anti-inflammatory activity of high-density lipoprotein (HDL). APL180 can be used in researches of cardiovascular diseases.
-
Lp(a)-IN-6
0 ImagesCat. No.: HY-171465CAS No.: 2566425-77-0Lp(a)-IN-6 (Compound 6) is a lipoprotein(a) (Lp(a)) inhibitor, with an IC50 of <0.314 nM. Lp(a)-IN-6 can be used for the research of cardiovascular disease (CVD).
-
1-Linoleoyl Glycerol-d5
0 ImagesCat. No.: HY-W778692CAS No.: 1795137-84-6Synonyms: 1-Linoleoyl-rac-glycerol-d5; 1-Monolinolein-d51-Linoleoyl Glycerol-d5 (1-Linoleoyl-rac-glycerol-d5; 1-Monolinolein-d5) is the deuterium labeled 1-Linoleoyl Glycerol (HY-111346). 1-Linoleoyl glycerol is a LpPLA2 inhibitor. 1-Linoleoyl glycerol acts as a precursor for synthesizing various functional lipids, such as phospholipids. 1-Linoleoyl glycerol mitigates inflammation induced by Apolipoprotein CIII (reduction of IL-6).
-
FAM labled Zerlasiran sodium
0 ImagesCat. No.: HY-147425DSynonyms: FAM labled SLN360 sodiumFAM labled Zerlasiran sodium is a FAM labled Zerlasiran sodium (HY-147425A). Zerlasiran sodium is a siRNA targeting apolipoprotein A (ApoA). Zerlasiran sodium targets hepatic ApoA synthesis via RNA interference to degrade encoding mRNA. Zerlasiran sodium can be used for the research of atherosclerotic cardiovascular disease and elevated ApoA levels.
-
Obicetrapib potassium
0 ImagesCat. No.: HY-18778BCAS No.: 866399-90-8Synonyms: TA-8995 potassium; DEZ-001 potassium; AMG-899 potassiumObicetrapib (TA-8995; DEZ-001) potassium is an orally active cholesteryl ester transfer protein (CETP) inhibitor. Obicetrapib potassium potently reduces atherogenic lipoproteins (such as LDL-C, ApoB, Lp (a)) and increases HDL-C. Obicetrapib potassium can be used for the research of dyslipidemia and atherosclerotic cardiovascular disease (ASCVD).
-
LVGRQLEEFL (mouse)
0 ImagesCat. No.: HY-P5169CAS No.: 608513-82-2LVGRQLEEFL (mouse) can be named as G * peptide, corresponding to amino acids 113 to 122 in apolipoprotein J ([113,122] apoJ)}. LVGRQLEEFL (mouse) exhibits anti-inflammatory and anti-atherogenic properties. LVGRQLEEFL (mouse) can be added to an apoJ mimetic, to form HM-10/10 peptide, which is a mimetic peptide and a novel chimeric high density lipoprotein. HM-10/10 peptide protects retinal pigment epithelium (RPE) and photoreceptors from oxidant induced cell death.
-
APOL1-IN-2
0 ImagesCat. No.: HY-169932CAS No.: 2956781-84-1APOL1-IN-2 (Compound 467) is the inhibitor for Apolipoprotein 1 (APOL1). APOL1-IN-2 reduces the APOL1 G2/G1 induced cell death in HEK293 with EC50 of 4.74 nM and 14.3 nM. APOL1-IN-2 reduces the APOL1 G2/G1/G0 induced death of trypanosomes with EC50 of 2.24, 6.03 and 3.72 nM, respectively.
